Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (12 quarters reported)
$117M in Q4 2022 → — now. Hover for any quarter.
As reported for the quarter ended September 30, 2025. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| 0 0 | NaN% | Unchanged | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2025 · filed November 03, 2025
No position changes this quarter.
quarter ended June 30, 2025 · filed August 07, 2025
No position changes this quarter.
quarter ended March 31, 2025 · filed May 01, 2025
No position changes this quarter.
quarter ended December 31, 2024 · filed February 05, 2025
No position changes this quarter.
quarter ended September 30, 2024 · filed October 31, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Akili Inc | Exited | −11,873,000 | −$5.16M | — |
| 0 0 | New | +0 | — | — |
quarter ended June 30, 2024 · filed August 02, 2024
No position changes this quarter.
quarter ended March 31, 2024 · filed May 08, 2024
No position changes this quarter.
quarter ended December 31, 2023 · filed February 09, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Prokidney Corp | Exited | −11,573,000 | −$53M | — |
Loading...
